Transdermal penetrant formulations containing cannabidiol

US11026896B2 · kind B2 · utility

Assignee

• DYVE BIOSCIENCES, INC. · US

Inventors

• Nathan Fitzsimmons · Thousand Oaks, US
• Ryan Beal · Thousand Oaks, US
• Audrene McMahon · Thousand Oaks, US
• Brandon Sand · Thousand Oaks, US
• Kilmar Martinez · Thousand Oaks, US

Key dates

• Filing date: Aug 20, 2019
• Grant date: Jun 8, 2021
• Expiry date: Aug 20, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein is a transdermal delivery formulation for transdermal delivery of a Cannabidiol, with or without one or more additional active agents through the dermis, including the skin, nail or hair follicle of a subject, wherein the formulation comprises a) a transdermal delivery formulation in an amount less than about 60% w/w, comprising i. one or more phosphatides, ii. glucose, and iii. one or more fatty acids; b) water in an amount less than about 50% w/w, a Cannabidiol with or within one or more additional active agents.